Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
07/2007
07/04/2007EP1375496B1 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient
07/04/2007EP1260512B1 Novel cyclic amide derivatives
07/04/2007CN1993360A Condensed pyridines as kinase inhibitors
07/04/2007CN1993340A Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
07/04/2007CN1324032C Novel 9-nitro campotothecin crystal form and medicinal composition
07/03/2007US7238709 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence
07/03/2007US7238695 Imidazolyl derivatives
07/03/2007US7238694 Rifamycin imino derivatives effective against drug-resistant microbes
07/03/2007US7238690 Substituted heterocycle fused gamma-carbolines
07/03/2007CA2168021C Vasoconstrictive dihydrobenzopyran derivatives
06/2007
06/28/2007WO2007071434A1 Antiviral 2-carboxy-thiophene compounds
06/28/2007WO2007070984A1 Spiroketals
06/28/2007US20070149585 Compounds useful as serotonin inhibitors and 5-HT1A agonists and antagonists
06/28/2007US20070149583 Diazonamide a analog
06/28/2007US20070149520 HCV Inhibitors And Methods Of Using Them
06/28/2007US20070149518 Oxazoloisoquinoline derivatives as thrombin receptor antagonists
06/28/2007US20070149516 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
06/28/2007US20070149503 Anti-migraine spirocycles
06/28/2007US20070149502 Spirocyclic anti-migraine compounds
06/28/2007US20070148093 Non-terminal method of identifying anti-migraine compounds
06/28/2007DE102005062098A1 Oxaphenanthren-Derivate Oxaphenanthren derivatives
06/28/2007CA2634468A1 Spiroketals
06/27/2007EP1799681A1 Condensed tricyclic benzimidazoles for the treatment of gastrointestinal disorders
06/27/2007EP0863903B1 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof
06/27/2007CN1989127A Kynurenic acid amide derivatives as NR2B receptor antagonists
06/27/2007CN1989124A Quinazolin-4-yl- piperidine and cinnolin-4-yl- piperidine derivatives as pde10 inhibitors for the treatment of cns disorders
06/27/2007CN1989117A Substituted benzothiazoles
06/27/2007CN1988907A Dual small molecule inhibitors of cancer and angiogenesis
06/27/2007CN1986548A Industrial continuous preparing process of N-tert-butoxy carbonyl-5-aza-2-oxa-3-one-dicyclo-[2,2,1] heptane
06/27/2007CN1986547A Industrial preparing process of N-tert-butoxy carbonyl-5-aza-2-oxa-3-one-dicyclo-[2,2,1] heptance in one cauldron
06/27/2007CN1986546A Geldanamycin derivative and its preparing method and use
06/27/2007CN1323082C Indicated tetraodotoxin, preparation and use thereof
06/27/2007CN1323081C Preparation of tetraodotoxin by two-step resin method and tetraodotoxin preparation thereof
06/26/2007USRE39707 Camptothecin derivatives
06/26/2007US7235674 3-Cyano-7-methoxy-4-(3-bromo-4,5-dimethoxyphenyl)-2-oxo-2H-chromene; 7-Amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-2-imino-2H-chromene; anticancer, antitumor agent
06/26/2007US7235663 E.g., 2,6-Diethyl-4,4-dimethoxy-2,3,6-trimethyl-1-(1-(4-oxir-anylmethoxy-phenyl) -ethoxy)-piperidine or 7,9-Diethyl-2,6, 7,9-tetramethyl-8-(1-(4-oxiranylmethoxy-phenyl)-ethoxy)-1,4-dioxa-8-aza -spiro(4.5)decane; anionic polymerization
06/26/2007US7235662 useful in treating diseases requiring glucocorticoid receptor agonist or antagonist therapy such as obesity, diabetes and inflammatory or immune associated diseases
06/26/2007US7235661 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
06/26/2007US7235575 Guanidine mimics as factor Xa inhibitors
06/21/2007WO2007070703A2 Sinomenine derivatives and preparation and uses thereof
06/21/2007WO2007070613A2 Rifamycin analogs and uses thereof
06/21/2007WO2007069727A1 Agent for prevention and treatment of acute renal failure
06/21/2007WO2007069635A1 Vla-4 inhibitory drug
06/21/2007WO2007068188A1 Camptothecin compounds with a substituent located in 10-position comprising multi-carboxyl groups, their preparation processes and their pharmaceutical compositions
06/21/2007WO2006133261A3 Organic compounds
06/21/2007US20070142423 Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders
06/21/2007US20070142419 Thienyl Compounds
06/21/2007US20070142377 Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives
06/21/2007US20070142370 Azabicyclooctan-3-one derivatives and use thereof
06/21/2007US20070142350 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates
06/21/2007US20070142347 CHONDROPSIN-CLASS ANTITUMOR V-ATPase INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
06/21/2007US20070142331 Lipophilic anticancer drug compounds, compositions and related methods
06/21/2007US20070142305 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; platelet-derived growth factor receptor (PDGF-R)
06/21/2007US20070142301 inhibit HCV NS3/NS4a serine protease activity; modulate the processing of hepatitis C virus (HCV) polypeptide
06/21/2007US20070141715 Quantitative method of determining beryllium or a compound thereof in a sample
06/21/2007US20070141093 an oil-in-water emulsion, a water-in-oil emulsion or micelle formulation selected from sebacate bis(paclitaxel-2'-yl) ester and sebacate bis(docetaxel-2'-yl) ester, used for for treating lung, mammary gland, colon or ovarian cancer
06/21/2007CA2633481A1 Preventive or therapeutic agent for acute renal failure
06/21/2007CA2632028A1 Rifamycin analogs and uses thereof
06/20/2007EP1798235A1 Acid addition salt of irinotecan
06/20/2007EP1798231A2 Intermediate products for the preparation of antibacterial compounds
06/20/2007EP1797100A1 Nitrate esters and their use for mitigating cellular damage
06/20/2007EP1797098A2 3-oxa-10-aza-phenanthrenes as pde4 or pde3/4 inhibitors
06/20/2007EP1797065A2 Acyclic 1,3-diamines and uses therefor
06/20/2007EP1796670A1 Process to prepare camptothecin derivatives and novel intermediate and compounds thereof
06/20/2007EP1796669A2 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/20/2007EP1796467A2 Imidazo{4,5-b}pyrazinone inhibitors of protein kinases
06/20/2007CN1984917A HIV integrase inhibitors: cyclic pyrimidinone compounds
06/20/2007CN1984900A Indole derivatives having piperidine rings
06/20/2007CN1982314A Methods for preparing irinotecan
06/20/2007CN1982313A Camptothecin compound containing multiple organic hydroxy-acid group on 10-bit substituent, its production and composition
06/20/2007CN1982296A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
06/20/2007CN1321996C Process for preparing 2-iminopyrrolidine derivatives
06/19/2007US7232819 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
06/19/2007CA2367868C 4,7-dichlororhodamine dyes useful as molecular probes
06/19/2007CA2271940C Novel phenanthridinium derivatives
06/14/2007WO2007067756A2 Certain chemical entities, compositions, and methods for modulating trpv1
06/14/2007WO2007066615A1 Novel activator of nuclear orphan receptor and use thereof
06/14/2007WO2007065888A1 Chromone derivatives useful as antagonists of vr1 receptors
06/14/2007WO2006104897A3 Cytoskeletal active compounds, composition and use
06/14/2007US20070135629 Isolation of ansamitocins
06/14/2007US20070135471 Reacting 1-chlorocarbonyl-4-piperidinopiperidine hydrochloride and 7-ethyl-10-hydroxycamptothecin in polar aprotic solvent with diisopropylethylamine in presence of catalytic amount of N-containing cyclic organic compound, and optionally in the presence of a water binding agent
06/14/2007US20070135454 Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1)
06/14/2007US20070135430 Administering a 1-(2-aminoalkyl)-1H-furo(2,3-g)indazole, e.g.,N-(3-hydroxy-2,2-dimethylpropyl)-1-((S)-2-aminopropyl)-1H-furo[2,3-g]indazole-7-carboxamide; serotonin receptor agonists
06/14/2007US20070135422 Nitrogen-containing bicycle heterocycles for use as antibacterials
06/14/2007US20070135405 Novel diazabicyclononene and tetrahydropyridine derivatives with a new polar side-chain
06/14/2007US20070135402 Azetidine ring compounds and drugs comprising the same
06/14/2007US20070134328 Oxymorphone controlled release formulations
06/14/2007US20070134161 Methods of determining beta-iii tubulin expression
06/14/2007CA2629608A1 Chromone derivatives useful as antagonists of vr1 receptors
06/13/2007EP1795527A1 Carbamoyl-substituted spiro derivative
06/13/2007EP1794122A1 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase i
06/13/2007EP1487840B1 Crystalline polymorphic form of irinotecan hydrochloride
06/13/2007EP1487839B8 Methods for producing norgalanthamine, as well as isomers, salts and hydrates thereof
06/13/2007CN1980936A 2,4,6-phenylsubstituted cyclic ketoenoles.
06/13/2007CN1980924A Dihydrotetrabenazines and pharmaceutical compositions containing them.
06/13/2007CN1980657A Novel antiviral helioxanthin analogs
06/13/2007CN1978448A 10-hydroxy camptothecin arginine salt, and its preparing method and use
06/13/2007CN1978447A 10-hydroxy camptothecin arginine salt, and its preparing method and use
06/13/2007CA2567922A1 Methods for preparing irinotecan
06/12/2007US7230116 For use as pesticides, microbicides and herbicides